Will IVUS Ever Take Off in Peripheral Vascular Interventions?
Experts at ISET 2024 made the case for IVUS, but given how slow uptake has been in the coronary space, the mood was a bit skeptical.
Source: tctmd.com
Robert Lookstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Robert Lookstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Robert Lookstein Today - Breaking & Trending Today
AI in Pulmonary Embolism: 'Transformative' for Patient Care
Two physicians at ISET 2024 shared their firsthand impressions of what AI can bring to PE diagnosis, triage, and treatment.
Source: tctmd.com
Injectable Angioplasty Balloon Catheter Transforms Peripheral Procedures, Users Report Reduced Equipment and Contrast Needs
First in-man experience exceeds expectations, cited as “game changer” for below-the-knee procedures
Source: dicardiology.com
VIVA23 Presents Outcomes of Late-breaking Science from Abbott's LIFE-BTK, RESOLV FIH Study, and IN.PACT AV Access Trial
The second round of late-breaking clinical trials were presented with results from three studies during the Vascular InterVentional Advances Conference, VIVA23, being held Oct. 30-Nov. 2 in Las Vegas, NV. Notably, results from Abbott’s LIFE-BTK randomized clinical trial (RCT) demonstrated that Esprit BTK (Abbott) reduces disease progression and helps improve medical outcomes compared to balloon angioplasty, the current state of care.
Source: dicardiology.com
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA23
/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...
Source: prnewswire.com